Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO >  DELIVERABLE VOLUME
Deliverable Volume      
Orchid Pharma Ltd.
BSE Code 524372
ISIN Demat INE191A01027
Book Value 263.83
NSE Code ORCHPHARMA
Dividend Yield % 0.00
Market Cap 31438.24
P/E 74.05
EPS 8.37
Face Value 10  
Exchange : Period From : Period To :
DateTotal VolumeDeliverable VolumeDeliverable Volume [%]
27-Feb-2026 1862 1335 71.70
26-Feb-2026 2292 1473 64.27
25-Feb-2026 4356 2734 62.76
24-Feb-2026 1623 1111 68.45
23-Feb-2026 2382 1702 71.45
20-Feb-2026 498 436 87.55
19-Feb-2026 175 145 82.86
18-Feb-2026 685 535 78.10
17-Feb-2026 591 431 72.93
16-Feb-2026 2116 1283 60.63
13-Feb-2026 2169 1606 74.04
12-Feb-2026 1454 1213 83.42
11-Feb-2026 908 627 69.05
10-Feb-2026 1647 922 55.98
09-Feb-2026 1141 872 76.42
06-Feb-2026 2083 1644 78.92
05-Feb-2026 1127 772 68.50
04-Feb-2026 1058 843 79.68
03-Feb-2026 3158 2338 74.03
02-Feb-2026 489 273 55.83
Page 1 of 2
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.